Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective National Study to Molecularly and Genetically Characterize Human Gliomas: The Glioma Molecular Diagnostic Initiative

NCT00031538 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT00031538
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00031538 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective National Study to Molecularly and Genetically Characterize Human Gliomas: The Glioma Molecular Diagnostic Initiative
Lead sponsor
National Cancer Institute (NCI)
Phase
Observational
Overall status
Terminated
Start date
March 1, 2002
Completion date
April 29, 2015
Enrollment
674 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

anaplastic astrocytoma, astrocytoma, glioblastoma multiforme, glioma, oligodendroglioma